These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21784144)

  • 1. Rational design and optimization of downstream processes of virus particles for biopharmaceutical applications: current advances.
    Vicente T; Mota JP; Peixoto C; Alves PM; Carrondo MJ
    Biotechnol Adv; 2011; 29(6):869-78. PubMed ID: 21784144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation vaccines and vectors: Designing downstream processes for recombinant protein-based virus-like particles.
    Effio CL; Hubbuch J
    Biotechnol J; 2015 May; 10(5):715-27. PubMed ID: 25880158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling electrostatic interactions of baculovirus vectors for ion-exchange process development.
    Vicente T; Peixoto C; Alves PM; Carrondo MJ
    J Chromatogr A; 2010 Jun; 1217(24):3754-64. PubMed ID: 20444457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aqueous two-phase systems: A viable platform in the manufacturing of biopharmaceuticals.
    Rosa PA; Ferreira IF; Azevedo AM; Aires-Barros MR
    J Chromatogr A; 2010 Apr; 1217(16):2296-305. PubMed ID: 19962707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate PAT solutions for biopharmaceutical cultivation: current progress and limitations.
    Mercier SM; Diepenbroek B; Wijffels RH; Streefland M
    Trends Biotechnol; 2014 Jun; 32(6):329-36. PubMed ID: 24732022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular targets for improved manufacturing of virus-based biopharmaceuticals in animal cells.
    Rodrigues AF; Carrondo MJ; Alves PM; Coroadinha AS
    Trends Biotechnol; 2014 Dec; 32(12):602-7. PubMed ID: 25450042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of current scalable methods for purification of viral vectors.
    Segura MM; Kamen AA; Garnier A
    Methods Mol Biol; 2011; 737():89-116. PubMed ID: 21590394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovative and economic potential of mammalian cell culture.
    Werner RG
    Arzneimittelforschung; 1998 Apr; 48(4):423-6. PubMed ID: 9608886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTS technologies in biopharmaceutical discovery.
    Wu G; Doberstein SK
    Drug Discov Today; 2006 Aug; 11(15-16):718-24. PubMed ID: 16846799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH measurement and a rational and practical pH control strategy for high throughput cell culture system.
    Zhou H; Purdie J; Wang T; Ouyang A
    Biotechnol Prog; 2010; 26(3):872-80. PubMed ID: 20039376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ligand density on the optimization of ion-exchange membrane chromatography for viral vector purification.
    Vicente T; Fáber R; Alves PM; Carrondo MJ; Mota JP
    Biotechnol Bioeng; 2011 Jun; 108(6):1347-59. PubMed ID: 21294110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control and analytical methods for baculovirus-based products.
    Roldão A; Vicente T; Peixoto C; Carrondo MJ; Alves PM
    J Invertebr Pathol; 2011 Jul; 107 Suppl():S94-105. PubMed ID: 21784235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Chromatography Purification of Virus-Based Biopharmaceuticals: A Shortcut Design Method.
    Silva RJS; Mendes JP; Carrondo MJT; Marques PM; Peixoto C
    Methods Mol Biol; 2020; 2095():367-384. PubMed ID: 31858479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and optimization of an adenovirus production process.
    Kamen A; Henry O
    J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational and systematic protein purification process development: the next generation.
    Nfor BK; Verhaert PD; van der Wielen LA; Hubbuch J; Ottens M
    Trends Biotechnol; 2009 Dec; 27(12):673-9. PubMed ID: 19815300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in primary recovery: centrifugation and membrane technology.
    Roush DJ; Lu Y
    Biotechnol Prog; 2008; 24(3):488-95. PubMed ID: 18410157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies and genetically engineered related molecules: production and purification.
    Roque AC; Lowe CR; Taipa MA
    Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.